DK1205559T3 - Fremgangsmåde til påvisning af patogene mikroorganismer og antimikrobielle midler, fremgangsmåde til vurdering af lægemiddelvirkningen af antimikrobielle midler, og antimikrobielle midler - Google Patents
Fremgangsmåde til påvisning af patogene mikroorganismer og antimikrobielle midler, fremgangsmåde til vurdering af lægemiddelvirkningen af antimikrobielle midler, og antimikrobielle midlerInfo
- Publication number
- DK1205559T3 DK1205559T3 DK00944390T DK00944390T DK1205559T3 DK 1205559 T3 DK1205559 T3 DK 1205559T3 DK 00944390 T DK00944390 T DK 00944390T DK 00944390 T DK00944390 T DK 00944390T DK 1205559 T3 DK1205559 T3 DK 1205559T3
- Authority
- DK
- Denmark
- Prior art keywords
- antimicrobials
- evaluating
- drug effect
- pathogenic microorganisms
- detecting pathogenic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21436999 | 1999-07-28 | ||
PCT/JP2000/004617 WO2001007643A1 (fr) | 1999-07-28 | 2000-07-11 | Methode de detection d'un micro-organisme pathogene et d'un agent antimicrobien, methode d'evaluation des effets medicamenteux de l'agent antimicrobien, et agent antimicrobien |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1205559T3 true DK1205559T3 (da) | 2009-09-28 |
Family
ID=16654658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00944390T DK1205559T3 (da) | 1999-07-28 | 2000-07-11 | Fremgangsmåde til påvisning af patogene mikroorganismer og antimikrobielle midler, fremgangsmåde til vurdering af lægemiddelvirkningen af antimikrobielle midler, og antimikrobielle midler |
Country Status (12)
Country | Link |
---|---|
US (2) | US7214506B2 (da) |
EP (2) | EP1205559B1 (da) |
JP (2) | JP4414623B2 (da) |
AT (1) | ATE434667T1 (da) |
AU (1) | AU5852400A (da) |
CA (1) | CA2391274C (da) |
CY (1) | CY1109281T1 (da) |
DE (1) | DE60042453D1 (da) |
DK (1) | DK1205559T3 (da) |
ES (1) | ES2328785T3 (da) |
PT (1) | PT1205559E (da) |
WO (1) | WO2001007643A1 (da) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060013862A1 (en) * | 2004-07-19 | 2006-01-19 | Held Jerry M | Onychomycosis: a new process for cure |
JP4824493B2 (ja) * | 2005-08-31 | 2011-11-30 | 株式会社ポーラファルマ | 抗真菌剤の評価法 |
US8889155B2 (en) | 2006-12-28 | 2014-11-18 | Kaken Pharmaceutical Co., Ltd. | Gel composition for treating mycosis |
JP5250561B2 (ja) * | 2007-12-25 | 2013-07-31 | 株式会社ポーラファルマ | 微生物感染症の動物感染モデル |
US20090175810A1 (en) | 2008-01-03 | 2009-07-09 | Gareth Winckle | Compositions and methods for treating diseases of the nail |
US20100291182A1 (en) * | 2009-01-21 | 2010-11-18 | Arsenal Medical, Inc. | Drug-Loaded Fibers |
US9044580B2 (en) | 2009-08-24 | 2015-06-02 | Arsenal Medical, Inc. | In-situ forming foams with outer layer |
US10420862B2 (en) | 2009-08-24 | 2019-09-24 | Aresenal AAA, LLC. | In-situ forming foams for treatment of aneurysms |
US9173817B2 (en) | 2009-08-24 | 2015-11-03 | Arsenal Medical, Inc. | In situ forming hemostatic foam implants |
US20110202016A1 (en) * | 2009-08-24 | 2011-08-18 | Arsenal Medical, Inc. | Systems and methods relating to polymer foams |
SG184563A1 (en) * | 2010-04-16 | 2012-11-29 | Zeus Scientific Inc | Methods for measuring enzyme activity useful in determining cell viability in non-purified samples |
US8039494B1 (en) * | 2010-07-08 | 2011-10-18 | Dow Pharmaceutical Sciences, Inc. | Compositions and methods for treating diseases of the nail |
US8968626B2 (en) | 2011-01-31 | 2015-03-03 | Arsenal Medical, Inc. | Electrospinning process for manufacture of multi-layered structures |
US9194058B2 (en) | 2011-01-31 | 2015-11-24 | Arsenal Medical, Inc. | Electrospinning process for manufacture of multi-layered structures |
US9034240B2 (en) | 2011-01-31 | 2015-05-19 | Arsenal Medical, Inc. | Electrospinning process for fiber manufacture |
US8993831B2 (en) | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
CA2924748C (en) | 2013-10-03 | 2019-09-03 | Dow Pharmaceutical Sciences, Inc. | Stabilized efinaconazole formulations |
CN112999223A (zh) | 2013-11-22 | 2021-06-22 | 博世健康爱尔兰有限公司 | 抗感染的方法、组合物和装置 |
EP3247399A4 (en) * | 2015-01-20 | 2018-09-05 | Wavelength Enterprises Ltd | Crystalline forms of efinaconazole |
KR102060546B1 (ko) | 2019-06-07 | 2019-12-30 | 주식회사 바이오빌리프 | 에피나코나졸을 함유하는 용액 형태의 국소 투여용 약학 조성물 |
JP7440073B2 (ja) | 2020-07-30 | 2024-02-28 | 国立大学法人広島大学 | 生存細菌の検出方法及びそのためのキット |
KR20220150829A (ko) | 2021-05-04 | 2022-11-11 | 주식회사 제뉴원사이언스 | 에피나코나졸을 함유하는 액상 형태의 약학적 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ233502A (en) * | 1989-06-09 | 1991-11-26 | Janssen Pharmaceutica Nv | 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions |
ATE161257T1 (de) | 1993-05-10 | 1998-01-15 | Kaken Pharma Co Ltd | Azolylamin-derivat |
AU686685B2 (en) * | 1993-10-25 | 1998-02-12 | Ribogene, Inc. | Methods for screening for antimycotics |
JP3404152B2 (ja) * | 1994-10-04 | 2003-05-06 | ポーラ化成工業株式会社 | 抗真菌剤の評価法 |
JP3129662B2 (ja) * | 1996-07-16 | 2001-01-31 | グンゼ株式会社 | 皮膚刺激判定法 |
DK0983037T3 (da) * | 1998-02-09 | 2003-09-01 | Macrochem Corp | Fungicid neglelak |
-
2000
- 2000-07-11 DK DK00944390T patent/DK1205559T3/da active
- 2000-07-11 WO PCT/JP2000/004617 patent/WO2001007643A1/ja active Application Filing
- 2000-07-11 PT PT00944390T patent/PT1205559E/pt unknown
- 2000-07-11 ES ES00944390T patent/ES2328785T3/es not_active Expired - Lifetime
- 2000-07-11 DE DE60042453T patent/DE60042453D1/de not_active Expired - Lifetime
- 2000-07-11 EP EP00944390A patent/EP1205559B1/en not_active Expired - Lifetime
- 2000-07-11 AU AU58524/00A patent/AU5852400A/en not_active Abandoned
- 2000-07-11 JP JP2001512909A patent/JP4414623B2/ja not_active Expired - Lifetime
- 2000-07-11 CA CA2391274A patent/CA2391274C/en not_active Expired - Lifetime
- 2000-07-11 AT AT00944390T patent/ATE434667T1/de active
- 2000-07-11 EP EP09163421A patent/EP2112228A1/en not_active Withdrawn
-
2003
- 2003-10-14 US US10/685,266 patent/US7214506B2/en active Active
-
2007
- 2007-03-27 US US11/728,766 patent/US20080003636A1/en not_active Abandoned
-
2009
- 2009-08-10 CY CY20091100847T patent/CY1109281T1/el unknown
- 2009-10-07 JP JP2009233792A patent/JP2010004893A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2010004893A (ja) | 2010-01-14 |
US20070082375A1 (en) | 2007-04-12 |
US20080003636A1 (en) | 2008-01-03 |
EP1205559B1 (en) | 2009-06-24 |
EP1205559A4 (en) | 2004-11-17 |
JP4414623B2 (ja) | 2010-02-10 |
ES2328785T3 (es) | 2009-11-18 |
ATE434667T1 (de) | 2009-07-15 |
WO2001007643A1 (fr) | 2001-02-01 |
EP1205559A1 (en) | 2002-05-15 |
CA2391274C (en) | 2010-12-14 |
AU5852400A (en) | 2001-02-13 |
EP2112228A1 (en) | 2009-10-28 |
CA2391274A1 (en) | 2001-02-01 |
US7214506B2 (en) | 2007-05-08 |
CY1109281T1 (el) | 2014-07-02 |
PT1205559E (pt) | 2009-08-04 |
DE60042453D1 (de) | 2009-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1205559T3 (da) | Fremgangsmåde til påvisning af patogene mikroorganismer og antimikrobielle midler, fremgangsmåde til vurdering af lægemiddelvirkningen af antimikrobielle midler, og antimikrobielle midler | |
BRPI0606969A2 (pt) | solução de bloqueio de cateter compreendendo citrato e um parabeno | |
MXPA05009352A (es) | Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas. | |
DE60131138D1 (de) | Antibakterielle mittel | |
WO2004027020A3 (en) | Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis | |
BR0200294B1 (pt) | sistema e mÉtodo de processamento de algodço. | |
WO2007053176A3 (en) | Method of protecting against staphylococcal infection | |
NO20025204D0 (no) | Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner | |
ATE531419T1 (de) | Vorrichtung zur verabreichung von therapeutischen mitteln | |
ATE335499T1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
EA200001197A1 (ru) | Усиление активности оксазолидиноновых антибактериальных агентов в результате применения производных аргинина | |
CY1105309T1 (el) | Συμπλεγμα εμβολιου που προοριζεται για προληψη και θepαπεια των λεϊσμανιασεων | |
DK1504088T3 (da) | Bakteriofager egnede til behandling og forebyggelse af bakterielle infektioner | |
WO2003082926A3 (en) | Antimicrobial polymer conjugates | |
DK2022786T3 (da) | Middel mod mund- og klovsyge-virus til dyr, der hører til familien suidae eller får, og fremgangsmåde til forebyggelse eller behandling af mund- og klovsyge hos dyr, der hører til familien suidae eller får | |
WO2000056333A8 (en) | Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance | |
ATE372132T1 (de) | Verfahren zum sterilisieren von gegenständen | |
ATE404215T1 (de) | Pharmazeutische zusammensetzung zur behandlung einer hiv-infektion | |
DK1184398T3 (da) | Oligomer til medier til indfangning af mikroorganismer, oligomerpolymeriseret vandholdig gel og oligomerpolymeriseret mikroorganismeindfangende gel | |
DE60140611D1 (de) | Verfahren zum evaluieren antifungaler agensien | |
WO2002002087A3 (de) | Anthelmintika zur verhinderung von parasitären infektionen bei menschen und tieren ii | |
DE60040874D1 (de) | Amplifizierung von hiv-1 sequenzen zur detektion ven einhergehen | |
FI20010352A0 (fi) | Menetelmä bakteerien ja bakteeriryhmien osoittamiseksi | |
ATE495757T1 (de) | Attenuierte bakterielle lebendvakzine | |
TH95334B (th) | การใช้ของวัคซีนสำหรับการรักษา/การป้องกันของการแพร่เชื้อของจุลชีพก่อโรค |